Clinical Trial Update: A Phase III Study of Apixaban in Patients With Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase III trial evaluating apixaban in patients with atrial fibrillation has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Eliquis (apixaban)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2013-11-14